Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tissue Diagnostics Market, by Product
1.4.2 Europe Tissue Diagnostics Market, by Technology
1.4.3 Europe Tissue Diagnostics Market, by Disease Type
1.4.4 Europe Tissue Diagnostics Market, by End User
1.4.5 Europe Tissue Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Porter Five Forces Analysis
Chapter 5. Europe Tissue Diagnostics Market by Product
5.1 Europe Consumables Market by Country
5.2 Europe Tissue Diagnostics Market by Consumables Product
5.2.1 Europe Antibodies Market by Country
5.2.2 Europe Kits Market by Country
5.2.3 Europe Reagents Market by Country
5.2.4 Europe Probes Market by Country
5.3 Europe Instruments Market by Country
5.4 Europe Tissue Diagnostics Market by Instruments Product
5.4.1 Europe Slide-staining Systems Market by Country
5.4.2 Europe Scanners Market by Country
5.4.3 Europe Tissue Processing Systems Market by Country
5.4.4 Europe Others Market by Country
Chapter 6. Europe Tissue Diagnostics Market by Technology
6.1 Europe Immunohistochemistry Market by Country
6.2 Europe In Situ Hybridization Market by Country
6.3 Europe Digital Pathology & Workflow Market by Country
6.4 Europe Special Staining Market by Country
Chapter 7. Europe Tissue Diagnostics Market by Disease Type
7.1 Europe Breast Cancer Market by Country
7.2 Europe Lymphoma Market by Country
7.3 Europe Prostate Cancer Market by Country
7.4 Europe Gastric Cancer Market by Country
7.5 Europe Non-small Cell Lung Cancer Market by Country
7.6 Europe Others Market by Country
Chapter 8. Europe Tissue Diagnostics Market by End User
8.1 Europe Hospitals Market by Country
8.2 Europe Research Laboratories Market by Country
8.3 Europe Pharmaceutical Organizations Market by Country
8.4 Europe Contract Research Organizations (CROs) Market by Country
8.5 Europe Others Market by Country
Chapter 9. Europe Tissue Diagnostics Market by Country
9.1 Germany Tissue Diagnostics Market
9.1.1 Germany Tissue Diagnostics Market by Product
9.1.1.1 Germany Tissue Diagnostics Market by Consumables Product
9.1.1.2 Germany Tissue Diagnostics Market by Instruments Product
9.1.2 Germany Tissue Diagnostics Market by Technology
9.1.3 Germany Tissue Diagnostics Market by Disease Type
9.1.4 Germany Tissue Diagnostics Market by End User
9.2 UK Tissue Diagnostics Market
9.2.1 UK Tissue Diagnostics Market by Product
9.2.1.1 UK Tissue Diagnostics Market by Consumables Product
9.2.1.2 UK Tissue Diagnostics Market by Instruments Product
9.2.2 UK Tissue Diagnostics Market by Technology
9.2.3 UK Tissue Diagnostics Market by Disease Type
9.2.4 UK Tissue Diagnostics Market by End User
9.3 France Tissue Diagnostics Market
9.3.1 France Tissue Diagnostics Market by Product
9.3.1.1 France Tissue Diagnostics Market by Consumables Product
9.3.1.2 France Tissue Diagnostics Market by Instruments Product
9.3.2 France Tissue Diagnostics Market by Technology
9.3.3 France Tissue Diagnostics Market by Disease Type
9.3.4 France Tissue Diagnostics Market by End User
9.4 Russia Tissue Diagnostics Market
9.4.1 Russia Tissue Diagnostics Market by Product
9.4.1.1 Russia Tissue Diagnostics Market by Consumables Product
9.4.1.2 Russia Tissue Diagnostics Market by Instruments Product
9.4.2 Russia Tissue Diagnostics Market by Technology
9.4.3 Russia Tissue Diagnostics Market by Disease Type
9.4.4 Russia Tissue Diagnostics Market by End User
9.5 Spain Tissue Diagnostics Market
9.5.1 Spain Tissue Diagnostics Market by Product
9.5.1.1 Spain Tissue Diagnostics Market by Consumables Product
9.5.1.2 Spain Tissue Diagnostics Market by Instruments Product
9.5.2 Spain Tissue Diagnostics Market by Technology
9.5.3 Spain Tissue Diagnostics Market by Disease Type
9.5.4 Spain Tissue Diagnostics Market by End User
9.6 Italy Tissue Diagnostics Market
9.6.1 Italy Tissue Diagnostics Market by Product
9.6.1.1 Italy Tissue Diagnostics Market by Consumables Product
9.6.1.2 Italy Tissue Diagnostics Market by Instruments Product
9.6.2 Italy Tissue Diagnostics Market by Technology
9.6.3 Italy Tissue Diagnostics Market by Disease Type
9.6.4 Italy Tissue Diagnostics Market by End User
9.7 Rest of Europe Tissue Diagnostics Market
9.7.1 Rest of Europe Tissue Diagnostics Market by Product
9.7.1.1 Rest of Europe Tissue Diagnostics Market by Consumables Product
9.7.1.2 Rest of Europe Tissue Diagnostics Market by Instruments Product
9.7.2 Rest of Europe Tissue Diagnostics Market by Technology
9.7.3 Rest of Europe Tissue Diagnostics Market by Disease Type
9.7.4 Rest of Europe Tissue Diagnostics Market by End User
Chapter 10. Company Profiles
10.1 F. Hoffmann-La Roche Ltd.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 SWOT Analysis
10.3 PHC Holdings Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental Analysis
10.3.4 Recent strategies and developments:
10.3.4.1 Partnerships, Collaborations, and Agreements:
10.3.5 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Abbott Laboratories
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Merck KGaA
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.6.6 SWOT Analysis
10.7 Sakura Finetek USA, Inc.
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 Abcam Plc
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 SWOT Analysis
10.9 Amos scientific Pty Ltd.
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Dakewe Biotech Co., Ltd.
10.10.1 Company Overview
10.10.2 SWOT Analysis
Unique Offerings 